Clinical trial
Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk (DCB-HBR Trial)
NCT05221931 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk (DCB-HBR Trial)
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 29, 2022
- Completion date
- December 31, 2028
- Enrollment
- 1,359 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.